Who cares about Brussels? Apparently scientists do, with over 200,000 application forms for its €4 billion fund already downloaded. What next? Commissioner Janez Potočnik wants an EU-wide debate.
In the lean years since the post-genomics bust, venture funding has been hard to come by for Europe’s biotech start-ups. Now they have polished up their business models, and valuations are low, attracting investors back in.
The Lisbon strategy aim of making Europe the leading knowledge-based economy remains a far-off aspiration. Now the UK wants a fresh approach to the single market to move things forward.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.